© Copyright khedmeh Wall
The SNS Insider report estimates the Mesenchymal Stem Cells Market size at USD 3.09 billion in 2023, with a projected CAGR of 13.02% to reach USD 9.30 billion by 2032.
The Mesenchymal Stem Cells (MSC) Market, valued at USD 3.09 billion in 2023, is projected to grow to USD 9.30 billion by 2032, fueled by a robust compound annual growth rate (CAGR) of 13.02% during the forecast period from 2024 to 2032. This growth is driven by the increasing adoption of MSCs in regenerative medicine and therapeutic applications, leveraging their unique ability to promote tissue repair, modulate immune responses, and potentially treat a wide array of medical conditions. Technological advancements in cell isolation, expansion, and delivery methods are enhancing the efficacy and scalability of MSC-based therapies, paving the way for broader clinical use and commercialization across global healthcare markets.
Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3948
KEY MARKET SEGMENTATION
By Products and Services
o Cells & Cell Lines
o Kits, Media, & Reagents
o Others
By Type
By Source of Isolation
By Indication
By Application
Segment Analysis
By Products and Services, Products segment dominated the growth of the mesenchymal stem cells market with more than 78.9% of market share in 2023, due to it focuses on innovation and market expansion of the cells and cell lines segment.
By Workflow, Culture & Cryopreservation segment dominated the growth of the mesenchymal stem cells market with more than 44.6% of market share in 2023, due to the rise in number of people are seeking cryopreservation services, which is necessary for the advanced market infrastructure.
By Type, Allogeneic segment dominated the growth of the mesenchymal stem cells market with more than 56.8% of market share in 2023, due to the rise in allogeneic MSC therapies for the safety in clinical trials.
Recent Developments
November 2023, BrainStorm Cell received approval from the U.S. FDA to discuss the regulatory path for NurOwn, an effective MSC-based therapy for Amyotrophic Lateral Sclerosis (ALS).
July 2023, PROMOCELL GMBH's launch of PromoExQ MSC Growth Medium XF provides is the solution for cultivating MSCs used in cell therapy manufacturing.
July 2023, Merck KGaA is invest to expand cell culture media production in the U.S. for the advanced manufacturing capabilities for MSC-based treatments.
January 2023, Stemedica Cell Technologies' initiation of Phase Iib/III clinical trials. This study evaluates the safety and efficacy of MSC therapy for chronic ischemic stroke patients.
Regional Analysis
The North America dominated the mesenchymal stem cells market with more than 44.3% of market share in 2023. Due to rise in the number of clinical trials for the MSC therapy for different diseases. The presence of major mesenchymal stem cells suppliers and companies headquartered in this region. Rise in the funding from government and private organizations, for R&D.
Europe has significant number of shares of the mesenchymal stem cells market. This growth is due to several factors such as the strong support from the governments for the research and development. Advanced research infrastructure. Active participation of key companies and research organizations across Europe.
The Asia Pacific region is the fastest growing region for the mesenchymal stem cells market due to collaborations between local and international companies, increase in the interest in stem cell therapies. The government and private sector funding in supporting the development and accessibility of MSC therapies.
Key Takeaways
Make Enquiry About Mesenchymal Stem Cells Market Report: https://www.snsinsider.com/enquiry/3948
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Mesenchymal Stem Cells Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Mesenchymal Stem Cells Market Segmentation, By Products and Services
Chapter 9 Mesenchymal Stem Cells Market Segmentation, By Type
Chapter 10 Mesenchymal Stem Cells Market Segmentation, By Source of Isolation
Chapter 11 Mesenchymal Stem Cells Market Segmentation, By Indication
Chapter 12 Mesenchymal Stem Cells Market Segmentation, By Application
Chapter 13 Mesenchymal Stem Cells Market - Regional Analysis
Chapter 14 Company profile
Chapter 15 Competitive Landscape
Chapter 16 Use Case and Best Practices
Chapter 17 Conclusion
Access This Full Report with Charts And Graphs @ https://www.snsinsider.com/reports/mesenchymal-stem-cells-market-3948
Other Related Report
Hepatitis B Vaccine Market Opportunity
High-Performance Liquid Chromatography Market Opportunity
Hip Replacement Market Opportunity
Hormonal Contraceptives Market Opportunity
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com/
The Wall